Professor Jonathan Schott named ARUK’s first Chief Medical Officer

National dementia research charity Alzheimer's Research UK (ARUK) has appointed UCL Professor Jonathan Schott as the charity's first ever Chief Medical Officer (CMO). In this new part-time position at the charity, Professor Schott will play a pivotal role supporting and shaping ongoing research, policy, advocacy and strategy work. He will work closely with ARUK's Senior Leadership team including the Board of Trustees to help deliver life-changing dementia research. Professor Schott will continue in his current roles as Professor of Neurology at the UCL Dementia Research Centre, UCL Queen Square Institute of Neurology and as an Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square. His time working within the NHS is spent running a busy cognitive disorders service with an emphasis on young onset and unusual dementias. Professor Schott's research focuses on how clinical assessment, brain imaging, and markers of disease can be combined to help spot the early signs of diseases like Alzheimer's in the brain before dementia symptoms show. His work leading ARUK's landmark Insight 46 study using the Medical Research Council's UCL-based National Survey of Health and Development British 1946 Birth Cohort, will continue alongside his duties as the charity's new CMO.